Jennison Associates
NVET

Jennison Associates’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Jennison Associates’s Portfolio NVET Stock Details NVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-262,056
Closed -$954K – 766
2015
Q3 		$954K Sell
262,056
-148,139
-36% -$675K ﹤0.01% 632
2015
Q2 		$2.03M Sell
410,195
-53,311
-12% -$369K ﹤0.01% 622
2015
Q1 		$3.72M Buy
+463,506
New +$4.39M ﹤0.01% 539

Other funds holding NVET

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Jennison Associates's NVET Position: Q4 2015 in Review

Jennison Associates sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q4 2015, closing a stake of 262,056 shares — an estimated $954K sold.

Jennison Associates first reported a position in NVET in Q1 2015 and held it in 3 quarters. The position peaked at $3.72M in Q1 2015. 20 funds tracked by Wall St. Rank hold NVET as of Q4 2015.

  • Jennison Associates reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q4 2015 after selling out during the quarter.
  • Jennison Associates sold 262,056 Nexvet Biopharma plc Ordinary Shares shares in Q4 2015, an estimated $954K.
  • Jennison Associates first reported a position in Nexvet Biopharma plc Ordinary Shares in Q1 2015 and held it in 3 quarters.
  • Jennison Associates's Nexvet Biopharma plc Ordinary Shares position peaked at $3.72M in Q1 2015.
  • 20 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q4 2015.

Based on Jennison Associates's 13F filing for Q4 2015, filed 10 Feb 2016.